Eicosanoid biosynthesis in human cardiovascular disease
- 1 March 1987
- journal article
- review article
- Published by Elsevier in Human Pathology
- Vol. 18 (3) , 248-252
- https://doi.org/10.1016/s0046-8177(87)80007-2
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Synthesis and structure of the platelet aggregation factor thromboxane A2Nature, 1985
- Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.Circulation, 1983
- Reduced prostacyclin production in patients with different manifestations of ischemic heart diseaseThe American Journal of Cardiology, 1982
- Release of prostacyclin into the bloodstream and its exhaustion in humans after local blood flow changes (ischemia and venous stasis)Thrombosis Research, 1979
- A sensitive radioimmunoassay for 6-keto-prostaglandin F1α: preliminary observations on circulating concentrationsProstaglandins and Medicine, 1978
- Prostacyclin is a circulating hormoneNature, 1978
- Generation of prostacyclin by lungs in vivo and its release into the arterial circulationNature, 1978
- UNSTABLE METABOLITES OF ARACHIDONIC ACID AND THEIR ROLE IN HAEMOSTASIS AND THROMBOSISBritish Medical Bulletin, 1978
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976
- Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proceedings of the National Academy of Sciences, 1975